Status:
COMPLETED
Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents
Lead Sponsor:
Pfizer
Conditions:
Growth Hormone Deficiency
Eligibility:
All Genders
15-20 years
Phase:
PHASE3
Brief Summary
To evaluate in boys and girls the improvement in body composition under GH treatment in adolescents with CO-GHD who remain partially GHD after GH discontinuation.
Eligibility Criteria
Inclusion
- Males or females : Chronological age \> or = 15 years and \< or = 20 years for females
- Chronological age \> or = 17 years and \< or = 20 years for males
- GHD of childhood onset treated for at least 2 years
- Last GH injection at least 12 months before baseline visit
Exclusion
- Turner's syndrome
- Chronic hepatic impairment as shown by GGT and / or ASAT and / or ALAT \> 2 X ULN
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
End Date :
April 1 2005
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00156143
Start Date
April 1 2002
End Date
April 1 2005
Last Update
July 30 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.